The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(Z)-5-(3-((4-Chlorobenzyl)oxy)benzylidene)-2-(methylthio)-1,5-dihydro-4H-imidazole-4-one ID: ALA4163505
PubChem CID: 145958034
Max Phase: Preclinical
Molecular Formula: C18H15ClN2O2S
Molecular Weight: 358.85
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CSC1=NC(=O)/C(=C/c2cccc(OCc3ccc(Cl)cc3)c2)N1
Standard InChI: InChI=1S/C18H15ClN2O2S/c1-24-18-20-16(17(22)21-18)10-13-3-2-4-15(9-13)23-11-12-5-7-14(19)8-6-12/h2-10H,11H2,1H3,(H,20,21,22)/b16-10-
Standard InChI Key: WQJGSVBTMYODME-YBEGLDIGSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
3.3182 -11.0211 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1378 -11.0223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5447 -10.3137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1373 -9.6076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3147 -9.6104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9073 -10.3154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3660 -10.3139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7786 -11.0258 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.5999 -11.0260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0050 -11.7386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8255 -11.7391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2393 -11.0269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8223 -10.3126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0031 -10.3155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2327 -9.6035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0540 -9.6008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5353 -10.2571 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5310 -8.9308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3132 -9.1806 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3138 -10.0001 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0204 -10.4091 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.2745 -8.1508 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0860 -10.3179 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
11.0195 -11.2263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
13 15 1 0
15 16 2 0
16 17 1 0
17 20 1 0
19 18 1 0
18 16 1 0
19 20 2 0
20 21 1 0
18 22 2 0
6 23 1 0
21 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 358.85Molecular Weight (Monoisotopic): 358.0543AlogP: 4.11#Rotatable Bonds: 4Polar Surface Area: 50.69Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.23CX LogD: 4.23Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.84Np Likeness Score: -0.94
References 1. Schoeder CT, Kaleta M, Mahardhika AB, Olejarz-Maciej A, Łażewska D, Kieć-Kononowicz K, Müller CE.. (2018) Structure-activity relationships of imidazothiazinones and analogs as antagonists of the cannabinoid-activated orphan G protein-coupled receptor GPR18., 155 [PMID:29902723 ] [10.1016/j.ejmech.2018.05.050 ]